sabarubicin has been researched along with taxane in 1 studies
Studies (sabarubicin) | Trials (sabarubicin) | Recent Studies (post-2010) (sabarubicin) | Studies (taxane) | Trials (taxane) | Recent Studies (post-2010) (taxane) |
---|---|---|---|---|---|
29 | 5 | 4 | 1,288 | 210 | 779 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adank, S; Caponigro, F; Capriati, A; Comandini, A; Demol, J; Floquet, A; Sorio, R; Tambaro, R; van Belle, S; Wanders, J; Willemse, P | 1 |
1 trial(s) available for sabarubicin and taxane
Article | Year |
---|---|
A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer.
Topics: Aged; Antineoplastic Agents; Bridged-Ring Compounds; Disaccharides; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Remission Induction; Salvage Therapy; Taxoids | 2005 |